Targeting conserved viral virulence determinants by single domain antibodies to block SARS-CoV2 infectivity
S. Singh, S. Dahiya, Y. J. Singh, K. Beeton, A. Jain, R. Sarkar, A. Dubey, S. A. Tehseen, S. Sehrawat
This study identifies single domain antibodies that neutralize SARS-CoV2 by targeting the cleavage site and receptor binding domain of the spike protein, showing their stability and effectiveness in blocking infectivity.
bioRxiv · Jan 13, 2021 · PreprintImmunology